Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-397 in Benign Prostatic Hyperplasia
NCT03246880Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil + tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Chong Kun Dang Holdings. Started Sep 2015; status: completed.
02
Drugs
tadalafil + tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT03246880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03246880.